Effects of 16 Weeks of Methylphenidate Treatment on Actigraph-Assessed Sleep Measures in Medication-Naive Children With ADHD

Effects of 16 Weeks of Methylphenidate Treatment on Actigraph-Assessed Sleep Measures in Medication-Naive Children With ADHD

Methylphenidate (MPH) improves behavioral symptoms of attention-deficit/hyperactivity disorder (ADHD). Its effects on sleep, however, are insufficiently known, as trials with MPH in medication-naive children were so far restricted to relatively short trial durations. Here, we assessed effects of pro...

Full description

Bibliographic Details
Main Authors: Michelle M. Solleveld, Anouk Schrantee, Hee Kyung Baek, Marco A. Bottelier, Hyke G. H. Tamminga, Cheima Bouziane, Reino Stoffelsen, Paul J. Lucassen, Eus J. W. Van Someren, Roselyne M. Rijsman, Liesbeth Reneman
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-02-01
Series:Frontiers in Psychiatry
Subjects:
sleep
ADHD
methylphenidate
actigraphy
randomized clinical trial
Online Access:https://www.frontiersin.org/article/10.3389/fpsyt.2020.00082/full

Internet

https://www.frontiersin.org/article/10.3389/fpsyt.2020.00082/full

Similar Items